March 27, 2026 · Form 4 insider transaction
Masoud Maher bought 600,000 shares of MaxCyte Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Twenty-five percent (25%) of the shares underlying this option shall vest on March 27, 2027, and the remainder shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.